A coastal research digest / common questions
Frequently Asked Questions About Sermorelin
Direct answers drawn from the published literature — efficacy, IGF-1, sleep, fat, the analog comparisons, and the honest limits of the adult data.
Does sermorelin work?
In healthy older men, GHRH(1-29) at 0.5-1 mg twice daily for 14 days produced dose-related increases in 24-hour GH and IGF-1, with high-dose values no longer differing from young men [5]. In GH-deficient children, once-daily subcutaneous GHRH(1-29) accelerated first-year height velocity from about 4.1 to 7-8 cm/year [2]. These are studied outcomes, not a treatment recommendation.
How long does it take for sermorelin to work?
Pharmacokinetic studies show GH rises within an hour of a single dose and stays elevated for roughly 3 hours despite the peptide's ~10-12 minute plasma half-life [3]. Changes in IGF-1 and body composition in adult research accrued over weeks of repeated dosing [5]. Reported in studies, not a personal timeline.
Will sermorelin raise my IGF-1 levels?
In healthy older men, 14 days of subcutaneous GHRH(1-29) produced dose-related rises in IGF-1, and at the high dose IGF-1 no longer differed from that of young men, with no change in fasting glucose [5]. IGF-1 is produced mainly by the liver in response to GH, so the rise follows GH stimulation.
Is 3 months of sermorelin enough?
Study durations vary widely. The adult GH-axis study in older men ran 14 days and still showed reversal of age-related GH/IGF-1 declines [5]; the pediatric efficacy trial measured first-year growth over 12 months [2]. There is no established adult anti-aging duration — long-term adult data remain limited [9].
Is long-term sermorelin use safe?
Long-term tolerability data specifically for adult use are limited, and an Annals of Internal Medicine editorial cautioned that growth-hormone-secretagogue use to prevent or treat aging is "not yet ready for prime time" [9]. Because GH and IGF-1 are mitogenic, chronically raising them is a recognized theoretical safety consideration [6]. This is research context, not safety guidance.
What is sermorelin?
Sermorelin is the amidated synthetic 29-amino-acid fragment (GHRH(1-29)NH2 / GRF(1-29)) corresponding to the active amino-terminal portion of growth-hormone-releasing hormone — the shortest fragment retaining full activity at the GHRH receptor [1]. It is a pituitary growth-hormone secretagogue; it was formerly FDA-approved as a pediatric GH-deficiency drug (withdrawn from the US market in 2008 for commercial reasons) and is now prepared by compounding pharmacies.
What does sermorelin do to the body?
It binds GHRH receptors on anterior-pituitary somatotrophs, activating the adenylate-cyclase / cAMP / PKA pathway to stimulate synthesis and pulsatile release of the body's own growth hormone, which in turn raises hepatic IGF-1 [1]. Because it acts upstream, somatostatin and IGF-1 negative feedback stay intact, preserving the natural pulsatile GH pattern [4][6].
How does sermorelin compare to CJC-1295?
Sermorelin is native GHRH(1-29) with a short ~10-12 minute plasma half-life [3]. That brevity motivated longer-acting analogs: a D-Ala2 substitution and the Drug Affinity Complex (DAC) technology behind CJC-1295, where a maleimide group binds serum albumin to extend the half-life. Both engage the same GHRH receptor; the difference is duration of action.
Sermorelin vs ipamorelin: what is the difference?
They act through different receptors. Sermorelin is a GHRH analog acting on the pituitary GHRH receptor; ipamorelin is a growth-hormone-releasing peptide (GHRP) acting on the ghrelin / GH-secretagogue receptor [6]. Mechanistically, combining a GHRH analog with a GHRP amplifies GH pulse amplitude versus either class alone.
What is sermorelin used for?
Its historical FDA-approved use was to accelerate growth in children with growth-hormone deficiency / short stature [2]. Subsequent research has studied GHRH(1-29) and its analogs in adult GH-axis aging, body composition, cognition, and sleep. It is studied as a research peptide; these pages describe findings, not human treatment.
Does sermorelin actually help with sleep, or is it waking me up instead?
Sleep onset and slow-wave sleep coincide with the nocturnal GH release that bedtime GHRH dosing leverages [13], and blocking GHRH receptors suppresses nocturnal GH without abolishing slow-wave sleep [14]. GHRH's efficacy in modulating sleep-endocrine activity is reduced in the elderly [15]. These are physiology findings, not a claim about individual sleep experience.
Why is it recommended to inject sermorelin at night?
GH is secreted in pulses, especially during slow-wave sleep, and slow-wave sleep coincides with the dominant nocturnal GH pulse [13]. Research protocols therefore administered GHRH(1-29) at bedtime to align with that endogenous pulse — the pediatric efficacy trial used once-daily subcutaneous bedtime dosing [2]. Described as a study protocol, not a dosing instruction.
Does sermorelin burn fat?
The GH/IGF-1 axis has a known role in body composition, and in the cognition RCT the stabilized GHRH analog tesamorelin reduced percent body fat by 7.4% over 20 weeks [10]. Reviews discuss GH/IGF-1-axis modulation among strategies for age-related change [11]. Anti-aging and body-composition marketing outpaces the evidence; these are studied outcomes, not proven benefits.
Does sermorelin build muscle?
A review frames GH/IGF-1-axis modulation, including GHRH secretagogues, among candidate strategies to counteract sarcopenia (age-related muscle loss) in older adults [11]. Sermorelin raises GH and IGF-1, which mediate anabolic signaling, but rigorous adult muscle-outcome data are limited and benefit is not established. Research context only.
How does sermorelin differ from direct HGH injections?
Sermorelin acts upstream on the pituitary to stimulate the body's own pulsatile GH, leaving somatostatin and IGF-1 feedback intact, whereas exogenous HGH supplies the hormone directly and bypasses that feedback. An editorial argues sermorelin may be a more physiologic approach to adult-onset GH insufficiency than recombinant GH [4].
Does sermorelin affect testosterone?
The research literature characterizes sermorelin as acting on the GH/IGF-1 somatotropic axis, distinct from the gonadal (testosterone) axis. The studies summarized here report GH and IGF-1 outcomes, not testosterone changes, so any testosterone link is not established in this evidence set. Described as research scope, not a recommendation.
Can sermorelin or GHRH improve cognition in older adults?
In a randomized, double-blind, placebo-controlled trial of 152 older adults (66 with mild cognitive impairment), 20 weeks of a daily GHRH analog (tesamorelin, 1 mg before bedtime) had a favorable effect on cognition (P=0.03), raised IGF-1 by 117% within the physiologic range, and cut body fat 7.4% (the SMART trial, NCT00257712) [10]. In aged rodents, chronic [D-Ala2]-GHRH attenuated age-related spatial-memory deficits [12].
What are the side effects of sermorelin?
Long-term tolerability data specifically for adult use remain limited [6]. Because GH and IGF-1 are mitogenic, chronically raising them is a recognized theoretical oncologic consideration for any GH-axis intervention, even though sermorelin works through the body's own feedback-regulated secretion. Authorities have cautioned that secretagogue use for aging is not established [9]. Research context, not a safety profile for use.
When is the best time to take sermorelin?
Research protocols specified bedtime administration to coincide with the dominant nocturnal GH pulse during slow-wave sleep [13][2]. Aligning dosing with that endogenous pulse is the rationale reported in the literature. Stated as a study-protocol observation, not a personal dosing instruction.
Sermorelin before and after: what changes do studies report?
Controlled studies report objective biomarker and growth changes rather than anecdotal transformations: dose-related rises in 24-hour GH and IGF-1 in older men, with high-dose values matching young men [5]; first-year height velocity rising from about 4.1 to 7-8 cm/year in GH-deficient children [2]; and, for the analog tesamorelin, IGF-1 +117% and body fat -7.4% over 20 weeks [10].